BioPharmaStock
HomeAsk About StockNewsIdeasHistoryFDA DesignationsElite Program

BEAT

No price yet

Announcements

Nothing here yet

Daily updates

  • HeartBeam received FDA Breakthrough Device Designation for its 3D ECG-based heart-attack evaluation platform.Oct 6, 2026

FDA designations

Nothing here yet

News

  • HeartBeam received a new U.S. patent expanding acoustic sensing and fluid monitoring capabilities for its wireless ECG deviceJul 14, 2026
  • HeartBeam initiates pilot study for on-demand 12-lead ECG patch to detect ischemia outside clinical settingsMay 11, 2026
  • HeartBeam receives FDA clearance for first cable-free synthesized 12-lead ECG for home arrhythmia assessmentDec 10, 2025

    Bio Pharma Stock

    Where Science Meets Investing.

    BioPharmaStock is a specialized biopharmaceutical investment intelligence company focused exclusively on publicly traded biotechnology and pharmaceutical companies. Our research team continuously analyzes clinical trials, FDA regulatory events, scientific publications, corporate developments, and market catalysts to deliver timely research and exclusive insights for investors seeking opportunities in one of the world's most knowledge-intensive sectors.

    ALNJAM ALAALI SOFTWARE DESIGN CO. L.L.C, UAE, Abu Dhabi

    BioPharmaStock LogoBioPharmaStock Logo

    Quick Links

    • Home
    • Ask About Stock
    • News
    • Ideas
    • History
    • FDA Designations
    • Elite Program

    Contact Us

    Email: info@biopharmastock.com

    Phone: +971 50 936 3328

    Join Our Community→

    Follow Us

    Get the App

    Instant notifications on your phone

    Download on theApp StoreGet it onGoogle Play

    © 2026 Bio Pharma Stock. All rights reserved. Policy